US Bancorp’s Mereo BioPharma MREO Stock Holding History

US Bancorp’s Portfolio MREO Stock Details MREO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4	Hold	13	–	–	﹤0.01%	4152
2026 Q1	$4	Hold	13	–	–	﹤0.01%	4161
2025 Q4	$5	Hold	13	–	–	﹤0.01%	4029
2025 Q3	$27	Hold	13	–	–	﹤0.01%	3983
2025 Q2	$35	Hold	13	–	–	﹤0.01%	4132
2025 Q1	$29	Hold	13	–	–	﹤0.01%	4160
2024 Q4	$46	Hold	13	–	–	﹤0.01%	4123
2024 Q3	$53	Hold	13	–	–	﹤0.01%	4045
2024 Q2	$47	Sell	13 -400	-97%	-$1.3K	﹤0.01%	3938
2024 Q1	$1.36K	Buy	413 +400	+3,077%	+$1.35K	﹤0.01%	3782
2023 Q4	$30	Hold	13	–	–	﹤0.01%	3938
2023 Q3	$17	Hold	13	–	–	﹤0.01%	3964
2023 Q2	$17	Hold	13	–	–	﹤0.01%	3970
2023 Q1	$9	Hold	13	–	–	﹤0.01%	4071
2022 Q4	$10	Hold	13	–	–	﹤0.01%	4125
2022 Q3	$0	Hold	13	–	–	﹤0.01%	4158
2022 Q2	$0	Hold	13	–	–	﹤0.01%	4158
2022 Q1	$0	Hold	13	–	–	﹤0.01%	4148
2021 Q4	$0	Buy	+13	New	+$26	﹤0.01%	4182

Other funds holding MREO

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

DCM

Defilade Capital Management Emeryville, California $747M AUM

Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return

Tejara Capital London, United Kingdom $243M AUM 9.84% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

US Bancorp's MREO Position: Q2 2026 in Review

US Bancorp held its Mereo BioPharma (MREO) position steady in Q2 2026 at 13 shares worth $4. The position accounts for ﹤0.01% of the portfolio, ranked #4152.

US Bancorp first reported a position in MREO in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.36K in Q1 2024. 61 funds tracked by Wall St. Rank hold MREO as of Q2 2026.

US Bancorp held 13 shares of Mereo BioPharma worth $4 as of Q2 2026.
US Bancorp left its Mereo BioPharma share count unchanged in Q2 2026.
Mereo BioPharma made up ﹤0.01% of US Bancorp's portfolio in Q2 2026, its #4152 holding.
US Bancorp first reported a position in Mereo BioPharma in Q4 2021 and has held it in 19 quarters since.
US Bancorp's Mereo BioPharma position peaked at $1.36K in Q1 2024.
61 funds tracked by Wall St. Rank held Mereo BioPharma as of Q2 2026.

Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.